Atlas Trials

Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid Arthritis

Clinical trial NCT03387423 · COMPLETED

Trial details

NCT number
NCT03387423
Sponsor
Pfizer
Status
COMPLETED
Study type
OBSERVATIONAL
Arthritis, Rheumatoid
Start date
2017-11-02
Primary completion
2023-07-17
Enrollment
1459

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.